| Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran M Salehi-Vaziri, T Jalali, B Farahmand, F Fotouhi, M Banifazl, ... European Journal of Clinical Microbiology & Infectious Diseases 40, 1713-1719, 2021 | 35 | 2021 |
| Updated studies on the development of HIV therapeutic vaccine MS Larijani, A Ramezani, SM Sadat Current HIV research 17 (2), 75-84, 2019 | 34 | 2019 |
| Bioinformatics analysis of SARS-CoV-2 to approach an effective vaccine candidate against COVID-19 SM Sadat, MR Aghadadeghi, M Yousefi, A Khodaei, M Sadat Larijani, ... Molecular biotechnology 63 (5), 389-409, 2021 | 28 | 2021 |
| SARS-CoV-2 re-infection rate in Iranian COVID-19 cases within one-year follow-up M Salehi-Vaziri, MH Pouriayevali, F Fotouhi, T Jalali, M Banifazl, ... Microbial pathogenesis 161, 105296, 2021 | 27 | 2021 |
| Prolonged viral shedding and antibody persistence in patients with COVID-19 F Fotouhi, M Salehi-Vaziri, B Farahmand, E Mostafavi, MH Pouriayevali, ... Microbes and Infection 23 (4-5), 104810, 2021 | 26 | 2021 |
| Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors M Zadsar, A Aghakhani, M Banifazl, M Kazemimanesh, ... Journal of medical virology 90 (8), 1318-1322, 2018 | 24 | 2018 |
| Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran MS Larijani, F Ashrafian, FB Amiri, M Banifazl, A Bavand, A Karami, ... Microbial pathogenesis 169, 105618, 2022 | 22 | 2022 |
| SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms M Sofian, AA Velayati, M Banifazl, F Fotouhi, M Sadat Larijani, N Afzali, ... Wiener Medizinische Wochenschrift 171, 3-6, 2021 | 22 | 2021 |
| SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses M Salehi-Vaziri, MD Omrani, MH Pouriayevali, F Fotouhi, M Banifazl, ... Virus research 299, 198421, 2021 | 17 | 2021 |
| In silico design and immunologic evaluation of HIV-1 p24-Nef fusion protein to approach a therapeutic vaccine candidate MS Larijani, SM Sadat, A Bolhassani, MH Pouriayevali, G Bahramali, ... Current HIV research 16 (5), 322-337, 2018 | 17 | 2018 |
| PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals A Ramezani, R Sorouri, S Haji Maghsoudi, S Dahmardeh, D Doroud, ... Scientific Reports 13 (1), 8065, 2023 | 14 | 2023 |
| Production of recombinant HIV-1 p24-Nef protein in two forms as potential candidate vaccines in three vehicles MS Larijani, MH Pouriayevali, SM Sadat, A Ramezani Current drug delivery 17 (5), 387-395, 2020 | 14 | 2020 |
| Induction of a robust humoral response using HIV-1 VLPMPER-V3 as a novel candidate vaccine in BALB/C mice F Tohidi, SM Sadat, A Bolhassani, R Yaghobi, MS Larijani Current HIV research 17 (1), 33-41, 2019 | 14 | 2019 |
| Assessment of long-term adverse events regarding different COVID-19 vaccine regimens within an 18-month follow-up study M Sadat Larijani, R Sorouri, S Eybpoosh, D Doroud, L Moradi, ... Pathogens and Disease 81, ftad010, 2023 | 13 | 2023 |
| HIV-1 p24-nef DNA vaccine plus protein boost expands T-cell responses in BALB/c MS Larijani, SM Sadat, A Bolhassani, A Khodaie, MH Pouriayevali, ... Current drug delivery 18 (7), 1014-1021, 2021 | 13 | 2021 |
| Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine MS Larijani, A Ramezani, MMA Shirazi, A Bolhassani, MH Pouriayevali, ... Virus research 298, 198403, 2021 | 11 | 2021 |
| A shot at dendritic cell-based vaccine strategy against HIV-1 M Sadat Larijani, SM Sadat, A Bolhassani, A Ramezani Journal of Medical Microbiology and Infectious Diseases 7 (4), 89-92, 2019 | 10 | 2019 |
| Impact of TGF-β1 gene polymorphism (rs1800469) on treatment response to pegylated interferon/ribavirin in Iranian patients with hepatitis C MS Larijani, LN Rad, M Nikbin, N Bahiraei, F Javadi, M Daneshvar, ... Clin Lab 62, 609-614, 2016 | 8 | 2016 |
| A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports M Sadat Larijani, D Doroud, M Banifazl, A Karami, A Bavand, F Ashrafian, ... European Journal of Medical Research 28 (1), 542, 2023 | 7 | 2023 |
| Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine B Farahmand, MS Larijani, F Fotouhi, A Biglari, R Sorouri, FB Amiri, ... Heliyon 9 (10), 2023 | 7 | 2023 |
